Treatments for lowering glucose levels using FGF binding protein 3
AssigneeGeorgetown University
InventorAnton Wellstein
Life of this patent
Estimating the term…
Abstract
The invention relates to methods of lowering blood glucose levels in a subject, with the methods comprising administering fibroblast growth factor binding protein 3 (FGFBP3) or a variant thereof to a subject in need of having lower glucose levels.
Claims15
A method of lowering blood glucose levels in a subject in need thereof, the method comprising administering fibroblast growth factor binding protein 3 (FGFBP3) to the subject in need of lowering blood glucose levels.
A method of treating diabetes in a subject in need of treatment thereof, the method comprising administering fibroblast growth factor binding protein 3 (FGFBP3) to the subject in need of treatment of diabetes.
A method of treating hyperglycemia in a subject in need of treatment thereof, the method comprising administering fibroblast growth factor binding protein 3 (FGFBP3) to the subject in need of treatment of hyperglucemia.
Dependencies are inferred from the claim text.